Educational material on tobacco use and smoking cessation

Interactive e-learning content

	Smoking cessation in respiratory patients P. Katsaounou (Athens, Greece), Sofia Ravara (Covilhã, Portugal) Open

The WHO e-Learning course Training for primary care providers: brief tobacco interventions

The WHO e-Learning course “Training for primary care providers: brief tobacco interventions” is converted from Part III of WHO training package “Strengthening health systems for treating tobacco dependence in primary care”, which was published in 2013 to assist countries in taking one of their first steps towards providing comprehensive tobacco dependence treatment to all tobacco users by integrating brief tobacco interventions (brief advice) into primary care.

Guidelines

ERS Position Paper on Tobacco Harm Reduction ERS Tobacco Control Committee
Smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit Jiménez-Ruiz, C.A., Andreas, S., Lewis, K.E., et al. Eur Respir J 2015; 46: 61–79
Smoking and health: a physician’s responsibility American College of Chest Physicians, American Thoracic Society, Asia Pacific Society of Respirology, Canadian Thoracic Society, European Respiratory Society, International Eur Respir J, 1995, 8, 1808-1811
Education and Smoking Cessation S. Nardini Eur Respir Mon, 2000, 13, 41-57
Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy P. Tønnesen, L. Carrozzi, K.O. Fagerström, et al. Eur Respir J 2007; 29: 390-417

Webcasts

Past smoking does not influence response to biologic therapy in patients with severe asthma M. Rahman (Southampton, United Kingdom), P. Dennison (Southampton, United Kingdom), A. Azim (Southampton, United Kingdom), A. Freeman (Southampton, United Kingdom), H. Haitchi (Southampton, United Kingdom), R. Kurukulaaratchy (Southampton, United Kingdom), H. Rupani (Southampton, United Kingdom)
Differences in Innate Lymphoid Cell profiles between COPD, asthma, smoking controls and non-smoking healthy controls C. van Zelst (Rotterdam, Netherlands), J. In 'T Veen (Rotterdam, Netherlands), G. De Boer (Rotterdam, Netherlands), M. De Bruijn (Rotterdam, Netherlands), M. Van Nimwegen (Rotterdam, Netherlands), E. Van Der Ploeg (Rotterdam, Netherlands), L. Krabbendam (Rotterdam, Netherlands), D. Van Uden (Rotterdam, Netherlands), R. Stadhouders (Rotterdam, Netherlands), G. Tramper-Stranders (Rotterdam, Netherlands), G. Braunstahl (Rotterdam, Netherlands), R. Hendriks (Rotterdam, Netherlands)
Effect of an immediate, remote smoking cessation intervention vs usual care among participants enrolled in lung health check: QuLIT2 study. W. Parris (London, United Kingdom), K. Philip (London, United Kingdom), N. Kaur-Gill (London, United Kingdom), D. Flannery (London, United Kingdom), S. Buttery (London, United Kingdom), E. Bartlett (London, United Kingdom), A. Devaraj (London, United Kingdom), J. Addis (London, United Kingdom), S. Kemp (London, United Kingdom), M. Chen (London, United Kingdom), J. Derbyshire (London, United Kingdom), K. Morris (London, United Kingdom), A. Laverty (London, United Kingdom), N. Hopkinson (London, United Kingdom)
Continuous cough monitoring with AI. Cases: treatment response, smoking cessation and COVID-19 J. Gabaldón-Figueira (Pamplona, Spain), M. Galvosas (Wilmington, United States), V. Orrillo (Pamplona, Spain), I. Blavia (Pamplona, Spain), J. Chaccour (Pamplona, Spain), A. Fernandez-Montero (Pamplona, Spain), N. Umashankar (San Diego, United States), N. Armendáriz (Zizur Mayor, Spain), F. Javier Bartolomé (Zizur Mayor, Spain), E. M. Keen (Wilmington, United States), J. Brew (Wilmington, United States), P. M Small (Wilmington, United States), S. Grandjean Lapierre (Montreal, Canada), C. Chaccour (Pamplona, Spain)
Influence of parental disease phenotypes and smoking on fractional exhaled nitric oxide values in offspring S. Zaigham (Malmö, Sweden), R. Bertelsen (Bergen, Norway), S. Dharmage (Melbourne, Australia), V. Schlünssen (Aarhus, Denmark), N. Jögi (Bergen, Norway), L. Palacios-Gomez (Huelva, Spain), M. Holm (Gothenburg, Sweden), A. Oudin (Umeå, Sweden), M. Abramson (Melbourne, Australia), T. Sigsgaard (Aarhus, Denmark), R. Jõgi (Tartu, Estonia), C. Svanes (Bergen, Norway), A. Olin (Gothenberg, Sweden), B. Forsberg (Umeå, Sweden), C. Janson (Uppsala, Sweden), E. Nerpin (Uppsala, Sweden), A. Johannessen (Bergen, Norway), A. Malinovschi (Uppsala, Sweden)
Parental smoking predicts teenage smoking and e-cigarette use in Ireland-a longitudinal study S. Sunday (Dublin, Ireland), L. Clancy (Dublin, Ireland), J. Hanafin (Dublin, Ireland)
Novel messages on cigarette sticks and dissuasive cigarettes in smoking cessation and prevention I. Karagiannidis (Thessaloniki, Greece), E. Smyrnakis (Thessaloniki, Greece), A. Haidich (Thessaloniki, Greece), A. Pataka (Thessaloniki, Greece)
Relationship of smoking with current and future social isolation and loneliness: 12-year follow-up of 8,780 older adults in England K. Philip (London, United Kingdom), F. Bu (London, United Kingdom), M. Polkey (London, United Kingdom), J. Brown (London, United Kingdom), A. Steptoe (London, United Kingdom), N. Hopkinson (London, United Kingdom), D. Fancourt (London, United Kingdom)
Smoking and COVID-19 – what have we learned? S. Sohal (Launceston (TAS), Australia), T. Hird (United Kingdom), R. Van Zyl-Smit (Cape Town, South Africa)
The therapeutic potential of PD-1/PD-L1 blockade in smoking exposed emphysema J. Kim (Seoul, Republic of Korea), N. Kim (Seoul, Republic of Korea), C. Shon (Seoul, Republic of Korea), J. Huh (Seoul, Republic of Korea), K. Han (Seoul, Republic of Korea), K. Kim (Suwon, Republic of Korea), S. Shin (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea)
Most users quit e-cigarettes without succeeding to quit smoking L. Hedman (Umeå, Sweden), H. Backman (Umeå, Sweden), C. Stridsman (Umeå, Sweden), A. Lindberg (Umeå, Sweden), E. Rönmark (Umeå, Sweden)
The presence of smoking in popular movies available in online streaming platform. A relentless fire still burning. D. Lykouras (Patras, Greece), I. Giannakodimos (Patras, Greece), O. Lagiou (Patras, Greece), M. Tsiamita (Patras, Greece), S. Tsakas (Patras, Greece), K. Karkoulias (Patras, Greece)
Inpatient smoking cessation during COVID-19: a highly teachable moment F. Frost (Liverpool, United Kingdom), K. Maitland (Liverpool, United Kingdom), T. Green (Liverpool, United Kingdom), M. Clark (Liverpool, United Kingdom), A. Duffy (Liverpool, United Kingdom), G. Jones (Liverpool, United Kingdom)
Are electronic cigarettes the real solution to quit smoking? F. Andres Franch (Sueca (Valencia), Spain)
Perception of general practitioners for e-cigarettes as a smoking cessation aid: systematic review M. Selamoglu (Melbourne, Australia), B. Erbas (Melbourne, Australia), C. Barton (Melbourne, Australia)
What is the latest research on the influence of cigarette smoking, vaping and atmospheric pollution on lung function decline M. Boezen (Groningen, Netherlands)
Tobacco smoking and somatic mutations in human bronchial epithelium Sam Janes (London, United Kingdom)
E-cigarettes and smoking cessation: the evidence or the non-evidence C. Pisinger (Frederiksberg, Denmark)
Engaging patients in smoking cessation: from patient involvement to patient health education M. Fletcher (Cuckfield, United Kingdom)
How Austria may benefit from a comprehensive smoke-free policy: promoting population-based smoking cessation H. Moshammer (Wien, Austria)
Ensifentrine, a dual PDE3/PDE4 inhibitor, improves FEV1 regardless of smoking status or history of chronic bronchitis T. Rheault (London, United Kingdom), T. Bengtsson (Lund, Sweden), K. Rickard (London, United Kingdom)
Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages B. Zöhrer (Stockholm, Sweden), A. James (Stockholm, Sweden), N. Souihi (Stockholm, Sweden), B. Brundin (Stockholm, Sweden), R. Karimi (Stockholm, Sweden), D. Erle (San Francisco, United States of America), S. Dahlén (Stockholm, Sweden), C. Sköld (Stockholm, Sweden), Å. Wheelock (Stockholm, Sweden)
Association of low-intensity smoking with respiratory and lung cancer mortality P. Balte (New York, United States of America), S. Bhatt (Birmingham, United States of America), P. Chaves (Miami, United States of America), D. Couper (Chapel Hill, United States of America), N. Freedman (Rockville, United States of America), D. Jacobs Jr (Minneapolis, United States of America), M. Jones (Baltimore, United States of America), R. Kalhan (Chicago, United States of America), A. Mathew (Chicago, United States of America), R. Kronmal (Seattle, United States of America), L. Loehr (Chapel Hill, United States of America), S. London (Research Triangle park, United States of America), A. Newman (Pittsburgh, United States of America), G. O'Connor (Boston, United States of America), J. Schwartz (New York, United States of America), B. Smith (New York, United States of America), L. Smith (Chicago, United States of America), W. White (Jackson, United States of America), S. Yende (Pittsburgh, United States of America), E. Oelsner (New York, United States of America)
Asthma do not counteract smoking initiation L. Hedman (Umeå, Sweden), H. Backman (Umeå, Sweden), M. Andersson (Umeå, Sweden), C. Stridsman (Umeå, Sweden), E. Rönmark (Umeå, Sweden)
Outpatient smoking cessation: preliminary findings of a non-inferiority RCT comparing blended with face-to-face delivery mode L. Siemer (Enschede, Netherlands), M. Pieterse (Enschede, Netherlands), S. Ben Allouch (Amsterdam, Netherlands), M. Postel (Enschede, Netherlands), R. Sanderman (Groningen, Netherlands), M. Brusse-Keizer (Enschede, Netherlands)
"No Smoking Week" and other activities that clinicians can do or support L. Gorreto Lopez (Sta Maria del Camí, Spain)
Is nicotine the hidden link between COVID-19 and smoking? P. Russo (Rome, Italy)
Is smoking a major risk factor for COVID-19 infection and severe disease? F. Filippidis (Oxford, United Kingdom)
Are electronic cigarettes and heated tobacco efficient smoking cessation products? The smoker’s and public health perspective S. Belo Ravara (Covilhã, Portugal)
Smoking cessation services in Russia: do we meet the demand? Results from Russian tobacco control policy evaluation survey M. Gambaryan (Moscow, Russian Federation), A. Kalinina (Moscow, Russian Federation), M. Popovich (Moscow, Russian Federation), M. Starovoytov (Moscow, Russian Federation), M. Popovich (Moscow, Russian Federation), O. Drapkina (Moscow, Russian Federation)
Smoking during hospitalization and 1-month after discharge in Southern European countries C. Martinez ( Barcelona, Spain), A. Feliu ( Barcelona, Spain), M. Enriquez ( Barcelona, Spain), L. Anton ( Barcelona, Spain), R. Ripoll ( Barcelona, Spain), À. Ruz ( Barcelona, Spain), S. Belo Ravara (Covilhã, Portugal), I. Pascoal ( Braga, Portugal), L. Videira ( Covilhã, Portugal), S. Ferreira ( Guarda, Portugal), C. Correia ( Braga, Portugal), J. Precioso ( Braga, Portugal), E. Fernández ( Barcelona , Spain)
Effectiveness of free-of-charge smoking cessation medicine distribution campaigns O. Elbek (Istanbul, Turkey), B. Salepci (Istanbul, Turkey), E. Dagli (Istanbul, Turkey), F. Yildiz (Istanbul, Turkey), P. Ay (Istanbul, Turkey), U. Sonmez (Istanbul, Turkey), M. Guner (Istanbul, Turkey), M. Ceyhan (Istanbul, Turkey), T. Gezer (Istanbul, Turkey)
Electronic cigarettes for smoking cessation: an individual patient meta-analysis of randomized controlled trials R. Villalobos (Manila, Philippines), G. Ambrocio (Manila, Philippines), L. Fernandez (Manila, Philippines)
A meta-analysis of the effectiveness of smart phone applications to aid smoking cessation A. Barnett (Gold Coast, Australia), I. Yang (Brisbane, Australia), K. Hay (Brisbane, Australia), H. Ding (Brisbane, Australia), R. Bowman (Brisbane, Australia), K. Fong (Brisbane, Australia), H. Marshall (Brisbane, Australia)
Effect of quitting smoking on quality of life following a diagnosis of lung cancer R. Gemine (Llanelli, United Kingdom), R. Ghosal (Llanelli, United Kingdom), G. Collier (Llanelli, United Kingdom), K. Lewis (Llanelli, United Kingdom)
Preventing respiratory diseases: The WHO-ERS Smoking Cessation Training Project S. Belo Ravara (Covilhã, Portugal)
Predictors of E-Cigarette Use: Smoking and Self-Identified Depression and/or Anxiety L. Goodfellow (Atlanta, United States of America), M. Alqahtani (Birmingham, United States of America)
Smoking status and its impact on COPD: an analysis of the observational DACCORD study C. Criée (Bovenden, Germany), C. Vogelmeier (Marburg, Germany), R. Buhl (Mainz, Germany), V. Obermoser (Nuremberg, Germany), K. Berschneider (Nuremberg, Germany), P. Kardos (Frankfurt am Main, Germany), H. Worth (Fuerth, Germany)
Attitude towards cigarette or e-cigarette use and the smoking initiation year among young European adults G. Brozek (Katowice, Poland), J. Mateusz (Katowice, Poland), J. Zejda (Katowice, Poland), A. Shpakou (Grodno, Belarus), M. Poznanski (Lodz, Poland), T. Zielonka (Warsaw, Poland), L. Klimat?kaia (Krasnoyarsk, Russian Federation), Y. Loginovic (Kaunas, Lithuania), M. Rachel (Rzeszow, Poland), J. Gereová (Bratislava, Slovakia), L. Minarowski (Bialystok, Poland), P. Majek (Katowice, Poland), J. Lawson (Saskatoon, Canada)
Trends in smoking initiation in Australia over 70 years G. Caliskan (Verona, Italy), G. Pesce (Paris, France), M. Abramson (Melbourne, Australia), D. Bui (Melbourne, Australia), A. James (Nedlands, Australia), D. Jarvis (London, United Kingdom), M. Knuiman (Perth, Australia), C. Minelli (London, United Kingdom), A. Musk (Perth, Australia), S. Accordini (Verona, Italy), S. Dharmage (Melbourne, Australia), A. Marcon (Verona, Italy)
Consistent effects of atopy and smoking on FeNO in American and European large population-based samples T. Queirós Jacinto (Porto, Portugal), J. Fonseca (Porto, Portugal), B. Bake (Gothenburg, Sweden), K. Torén (Gothenburg, Sweden), A. Olin (Gothenburg, Sweden), K. Alving (Uppsala, Sweden)
Tobacco smoking as a risk factor of active tuberculosis in HIV-infected patients E. Kulabukhova (Moscow, Russian Federation), V. Zimina (Moscow, Russian Federation), A. Kravtchenko (Moscow, Russian Federation), S. Degtyareva (Moscow, Russian Federation), E. Beloborodova (Moscow, Russian Federation), A. Peregudova (Moscow, Russian Federation)
Health communication and smoking E. Dagli (Istanbul, Turkey)
Cigarette smoking extracts stimulated human neutrophils to release neutrophil extracellular traps through a mitochondrial ROS-dependent way J. Chen (Chengdu, China), T. Wang (Chengdu, China), X. Li (Chengdu, China), F. Wen (Chengdu, China)
Cigarette smoking altered gut microbiota in a mouse model: the microbial lung-gut axis W. Xiao (Chengdu, China), J. Fu (Chengdu, China), T. Miao (Chengdu, China), B. Mao (Chengdu, China)
Global Vision of the Document on smoking cessation training for medical school C. Jimenez Ruiz (Madrid, Spain)
How smoking modifies inflammation and immunology of asthma P. Barnes (London, United Kingdom)
Characteristics of the smoking asthmatic patient cluster - data from U-BIOPRED C. Rossios (London, United Kingdom), I. Adcock (London, United Kingdom)
A 12 month smoking cessation outcome-Allen Carr’s Easyway to Stop Smoking-a randomised clinical trial S. Keogan (Dublin, Ireland), S. Li (Dublin, Ireland), L. Clancy (Dublin, Ireland)
Financial incentives combined with a smoking cessation group training programme increase abstinence rates in employees: a cluster randomized trial O. van Schayck (Maastricht, Netherlands), F. Van Den Brand (Maastricht, Netherlands), G. Nagelhout (Maastricht, Netherlands), B. Winkens (Maastricht, Netherlands), N. Chavannes (Leiden, Netherlands)